Mutations in the DNA-binding Domain of the Transcription Factor Bright Act as Dominant Negative Proteins and Interfere with Immunoglobulin Transactivation

This publication has 28 references indexed in Scilit:

• The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations
  Cellular Immunology, 2004
• Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
  Proceedings of the National Academy of Sciences, 2002
• Transcriptional Activation by a Matrix Associating Region-binding Protein
  Journal of Biological Chemistry, 2001
• The Sequence of the Human Genome
  Science, 2001
• A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer
  Oncogene, 1998
• The Humandead ringer/brightHomolog,DRIL1:cDNA Cloning, Gene Structure, and Mapping to D19S886, a Marker on 19p13.3 That Is Strictly Linked to the Peutz–Jeghers Syndrome
  Genomics, 1998
• The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family.
  Genes & Development, 1995
• Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID Mice
  Science, 1993
• Colocalization of X-Linked Agammaglobulinemia and X-Linked Immunodeficiency Genes
  Science, 1993
• Effect of anti‐γ₃ antibodies on immunoglobulin isotype expression in lipopolysaccharide‐stimulated cultures of mouse spleen cells
  European Journal of Immunology, 1983